Table 1—

Baseline characteristics of patients

LiraglutidePlacebo
n2112
Demographics
    Men/women11/101/11
    Age (years)59.9 ± 11.060.1 ± 6.7
Anthropometrics
    BMI (kg/m2)36.8 ± 4.636.1 ± 3.4
Diabetes
    Duration (years)4.5 ± 6.43.3 ± 3.4
    HbA1c (%)7.4 ± 1.07.7 ± 1.6
    Fasting plasma glucose (mmol/l)10.7 ± 2.410.4 ± 2.8
    Previous diabetes treatment
        Diet4 (19)7 (58)
        OHA17 (81)5 (42)
  • Data are means ± SD or n (%).